Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) (Parenthetical)

v3.7.0.1
Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) (Parenthetical) - $ / shares
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Warrant [Member]    
Weighted average exercise price $ 4.95 $ 4.95
Convertible Notes Payable [Member]    
Weighted average exercise price $ 0.67 $ 0.67